查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1753302

全球抗菌止血凝膠市場

Antibacterial Hemostatic Gels
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 290 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2030年全球抗菌止血凝膠市場規模將達20億美元

全球抗菌止血凝膠市場規模預計在2024年為14億美元，到2030年將達到20億美元，在2024-2030年的分析期間內，複合年成長率為5.5%。尿液檢查套件是本報告分析的細分市場之一，預計其複合年成長率為6.6%，到分析期結束時將達到7.529億美元。血液學檢測套組細分市場在分析期間的複合年成長率預計為6.1%。

美國市場規模估計為 3.936 億美元，中國市場預期複合年成長率為 8.9%

美國抗菌止血凝膠市場規模預計2024年達到3.936億美元。預計到2030年，作為世界第二大經濟體的中國市場規模將達到4.048億美元，在2024-2030年的分析期內，複合年成長率為8.9%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為2.6%和5.5%。在歐洲，預計德國市場的複合年成長率為3.6%。

全球抗菌止血凝膠市場－主要趨勢與促進因素摘要

抗菌止血凝膠如何改變傷口處理通訊協定？

抗菌止血凝膠作為突破性的傷口護理產品，正逐漸興起，兼具快速止血和感染控制兩大重要功能。傳統傷口管理需要多個步驟和獨立的產品，一個用於止血，另一個用於抑制細菌生長。這些新型凝膠透過提供一體化解決方案，消除了這種細分步驟的需要，大大簡化了急診和外科護理。這些凝膠背後的技術通常基於天然或合成聚合物，這些聚合物能夠快速吸收血液，激活凝血機制，並同時釋放抗菌劑以降低感染風險。它們在時間緊迫和高感染風險的情況下尤其有用，例如創傷、戰場損傷、外科手術和慢性傷口護理。護理人員和戰地醫護人員使用它們在病人入院前快速穩定病情。它們易於用注射器或管子塗抹，因此在非醫療環境中也易於操作。臨床試驗表明，其中一些凝膠可以在60秒內止血，同時保持廣譜抗菌功效。此外，它們還可以減少全身性抗生素的需求，這在抗生素抗藥性日益受到關注的背景下尤其重要。隨著傷口處理通訊協定的演變，抗菌止血凝膠的雙重功效正迅速被應用於創傷套件、手術用套件和軍事醫療用品中，這標誌著現代醫學在出血和感染疾病治療方式上的模式轉移。

這項突破背後有哪些科學進步？

抗菌止血凝膠的興起很大程度上歸功於生醫材料科學和奈米技術的突破，這些突破促進了多功能生物活性化合物的開發。這些凝膠通常由幾丁聚醣、明膠、膠原蛋白等生物聚合物或能與人體凝血系統主動相互作用的合成衍生物所組成。為了增強抗菌活性，在凝膠基質中嵌入了銀奈米顆粒、氧化鋅和其他廣譜抗菌劑。有些配方利用生物響應釋放機制，僅在檢測到特定環境因素（如 pH 值或細菌活動變化）時釋放抗菌劑。這種精確性降低了細胞毒性並提高了治療效果。此外，研究人員已經開始加入具有靶向抗菌特性的胜肽和酶，使它們能夠主動破壞生物膜形成並抑制抗藥性菌株，如 MRSA 和銅綠假單胞菌。另一個重要進展是加入模擬凝血酶和纖維蛋白原等天然凝血因子的止血劑，促進出血性疾病患者的凝血。一些產品被設計為生物分解性和可吸收，無需移除，並最大限度地減少疤痕。這些科學創新不僅提升了產品性能，也拓展了從戰場和急救到術後傷口處理甚至牙科護理的潛在使用案例。凝膠黏度、組織黏附性和熱穩定性的持續改進，進一步支持了其在傳統醫院環境和行動醫療單位中的應用。因此，這些創新不僅使抗菌止血凝膠更有效，而且用途更廣泛，為其在醫療保健各個領域的應用鋪平了道路。

為什麼醫療保健產業迅速採用這種凝膠？

醫療產業對抗菌止血凝膠的快速採用，可歸因於臨床需求、經濟價值和監管支持的共同作用。醫院、外科中心和創傷科室面臨著巨大的壓力，需要在控制成本和嚴格遵守手術計畫的同時，降低感染率、改善病患預後。這些凝膠提供了一種高效的解決方案，同時解決了傷口護理中最重要的兩個問題：止血和預防感染。這種雙重功能顯著減少了每位患者使用的產品數量，簡化了庫存，並降低了整體護理成本。從工作流程的角度來看，這些凝膠的易用性和快速應用性可以縮短手術時間，並最大限度地降低高血容量手術中併發症的風險。由於其挽救生命的潛力和經過驗證的安全性，許多凝膠已獲得加速核准。此外，微創手術的興起也催生了對能夠在狹窄解剖空間內快速精準應用的產品的需求。公共衛生系統也逐漸認知到它們在災難準備和緊急醫療服務中的價值。各國政府已開始儲備這種凝膠，將其作為國家創傷套件的一部分，尤其是在易受自然災害和衝突影響的國家。此外，隨著人們對醫院內感染 (HAI) 的認知不斷提高，以及抗生素管理政策的推廣，醫院正在實施全面的創傷護理解決方案。在醫療資源有限的新興國家，這種多用途凝膠是一種以更少的設備和更少的專業培訓提供有效創傷護理的有效方法。抗菌止血凝膠的擴充性、高效性和臨床多功能性使其成為各級醫療保健領域極具吸引力的解決方案。

推動抗菌止血凝膠市場成長的關鍵因素有哪些？

抗菌止血凝膠市場的成長受到多種因素的驅動，這些因素源於技術進步、臨床通訊協定的變更以及醫療保健重點的不斷演變。首先，道路交通事故、工業事故、衝突地區等造成的創傷性損傷不斷增加，對兼具感染控制功能的快速反應止血產品的需求持續成長。其次，全球外科手術（包括擇期手術和急診手術）的增多，擴大了這些凝膠在醫院和門診的應用。第三，持續存在的全球抗生素抗藥性挑戰已將臨床重點轉向局部抗菌解決方案，而這些凝膠提供了一種在不影響感染控制的情況下減少全身性抗生素使用的可行方法。第四，生醫材料工程的發展使得生產出不僅高效、經濟高效且在各種溫度和環境條件下穩定的凝膠成為可能。第五，軍事和戰術醫療計畫的擴展發揮了關鍵作用，全球各國國防部門都將這些凝膠納入士兵和醫護人員的野戰套件中。第六，患者偏好不斷演變，越來越多的人尋求能夠更快康復、更低併發症風險和更少疼痛的治療方法。第七，門診和家庭醫療保健服務的成長正在開闢新的分銷管道，對方便用戶使用型多功能創傷護理產品的需求旺盛。最後，醫療保健投資者的大力支持以及生物技術公司與醫療機構之間的研發合作正在加速產品創新和市場滲透。這些因素共同推動了抗菌止血凝膠的強勁成長，使其成為已開發國家和開發中國家現代創傷護理的重要組成部分。

部分

產品（尿液分析檢測套組、血液學檢測套組、血壓監測設備、血糖監測設備、其他產品）；最終用途（居家醫療最終用途、診斷中心最終用途、醫院最終用途、診所最終用途、其他最終用途）

受訪公司範例（41家值得關注的公司）

  • 3M Company
  • Baxter International Inc.
  • BioTime, Inc.
  • CR Bard, Inc.（Becton Dickinson）
  • ConvaTec Group Plc
  • DePuy Synthes（Johnson & Johnson）
  • Fumedica AG
  • Haemonetics Corporation
  • HEMOTECH Biomed Pvt Ltd
  • Integra LifeSciences
  • Johnson & Johnson
  • Medtronic plc
  • Molnlycke Health Care
  • Novosorb Biodegradable Products
  • OMRON Corporation
  • Pfizer Inc.
  • Porcine Biotech
  • Smith & Nephew plc
  • Stryker Corporation
  • WoundCare Technologies

人工智慧整合

我們正在利用可操作的專家內容和人工智慧工具來改變市場和競爭情報。

Global 特定產業SLM 的典型規範，而是建立了一個從全球專家收集的內容庫，其中包括視訊錄影、部落格、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地、進出口狀況（成品和原始OEM）預測其競爭態勢的變化。這種複雜且多面向的市場動態預計將以多種方式影響競爭對手，包括銷貨成本成本 (COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 競賽

簡介目錄
Product Code: MCP36169

Global Antibacterial Hemostatic Gels Market to Reach US$2.0 Billion by 2030

The global market for Antibacterial Hemostatic Gels estimated at US$1.4 Billion in the year 2024, is expected to reach US$2.0 Billion by 2030, growing at a CAGR of 5.5% over the analysis period 2024-2030. Urinanalysis Testing Kits, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$752.9 Million by the end of the analysis period. Growth in the Hematology Testing Kits segment is estimated at 6.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$393.6 Million While China is Forecast to Grow at 8.9% CAGR

The Antibacterial Hemostatic Gels market in the U.S. is estimated at US$393.6 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$404.8 Million by the year 2030 trailing a CAGR of 8.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.6% and 5.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.6% CAGR.

Global Antibacterial Hemostatic Gels Market - Key Trends & Drivers Summarized

How Are Antibacterial Hemostatic Gels Transforming Wound Management Protocols?

Antibacterial hemostatic gels are emerging as a revolutionary class of wound care products that combine two critical functionalities-rapid hemostasis and infection control. Traditionally, wound management has required multiple steps and separate products: one for stopping bleeding, and another to prevent bacterial growth. These new gels eliminate the need for such segmentation by providing an all-in-one solution, drastically simplifying emergency and surgical care. The technology behind these gels is often based on natural or synthetic polymers that can rapidly absorb blood, activate clotting mechanisms, and simultaneously release antimicrobial agents to reduce the risk of infection. They are particularly useful in trauma cases, battlefield injuries, surgical procedures, and chronic wound care, where time is of the essence and infection risk is high. One of the most impactful applications of these gels is in pre-hospital emergency care, where paramedics and field medics can use them to stabilize patients quickly before hospital admission. Their ease of application-typically through a syringe or tube-makes them user-friendly even in non-medical settings. Clinical trials have shown that some of these gels can stop bleeding in under 60 seconds while maintaining broad-spectrum antibacterial efficacy. Furthermore, they reduce the need for systemic antibiotics, which is especially important in light of growing concerns around antibiotic resistance. As wound management protocols evolve, the dual-action functionality of antibacterial hemostatic gels is rapidly being integrated into trauma kits, surgical packs, and military medical supplies, signaling a paradigm shift in how bleeding and infection are addressed together in modern medicine.

What Are the Scientific Advancements Powering This Breakthrough?

The rise of antibacterial hemostatic gels is largely attributable to breakthroughs in biomaterials science and nanotechnology, which have enabled the development of multifunctional, bioactive compounds. These gels typically comprise biopolymers like chitosan, gelatin, collagen, or synthetic derivatives that interact positively with the body’s clotting system. To enhance antimicrobial action, silver nanoparticles, zinc oxide, or other broad-spectrum antibacterial agents are embedded into the gel matrix. Some formulations utilize bioresponsive release mechanisms-delivering the antibacterial agent only when certain environmental cues, such as pH change or bacterial activity, are detected. This precision reduces cytotoxicity and enhances therapeutic efficiency. Additionally, researchers have begun integrating peptides and enzymes with targeted antibacterial properties, which can actively disrupt biofilm formation and inhibit resistant bacterial strains such as MRSA and Pseudomonas aeruginosa. Another important development is the incorporation of hemostatic agents that mimic natural clotting factors, such as thrombin or fibrinogen, to accelerate coagulation even in patients with bleeding disorders. Several products are being engineered to be biodegradable and reabsorbable, which eliminates the need for removal and minimizes scarring. These scientific innovations are not just improving product performance but are also expanding the potential use cases-from battlefield and emergency care to post-operative surgical wound management and even dental procedures. The continuous refinement of gel viscosity, tissue adhesion, and thermal stability further supports their adoption in both traditional hospital settings and mobile medical units. As a result, these innovations are not only making antibacterial hemostatic gels more effective but also more versatile, opening up avenues for applications across multiple fields of medicine.

Why Is the Healthcare Industry Rapidly Adopting These Gels?

The healthcare industry’s swift embrace of antibacterial hemostatic gels can be attributed to a convergence of clinical need, economic value, and regulatory support. Hospitals, surgical centers, and trauma units are under immense pressure to reduce infection rates and improve patient outcomes while managing costs and adhering to stringent procedural timelines. These gels offer a highly efficient solution by addressing two of the most critical concerns in wound care simultaneously: bleeding control and infection prevention. This dual capability significantly reduces the number of products used per patient, streamlining inventory and lowering overall treatment costs. From a workflow perspective, the ease of use and rapid application of gels can reduce procedural times in surgeries and minimize the risk of complications during high-blood-loss operations. The adoption is further accelerated by favorable regulatory classifications in several countries, with many gels receiving expedited approvals due to their life-saving potential and proven safety profiles. Additionally, the rise in minimally invasive procedures has created demand for products that can be applied quickly and with precision in constrained anatomical spaces-something these gels are uniquely suited for. Public health systems are also recognizing their value in disaster preparedness and emergency medical services. Governments are beginning to stockpile these gels as part of national trauma kits, especially in countries prone to natural disasters or conflict. Furthermore, increasing awareness of hospital-acquired infections (HAIs) and the push toward antimicrobial stewardship policies are encouraging hospitals to adopt integrated wound care solutions. In emerging economies, where medical resources are limited, these multipurpose gels present an efficient way to deliver effective wound care with fewer supplies and less specialized training. The scalability, efficiency, and clinical versatility of antibacterial hemostatic gels make them a highly attractive solution across all tiers of healthcare delivery.

What Are the Key Factors Driving Market Growth for Antibacterial Hemostatic Gels?

The growth in the antibacterial hemostatic gels market is driven by several factors rooted in technological advancements, changing clinical protocols, and evolving healthcare priorities. First, the increasing incidence of traumatic injuries-whether from road accidents, industrial mishaps, or conflict zones-is creating consistent demand for rapid-response hemostatic products that also provide infection control. Second, the rise in surgical procedures worldwide, including both elective and emergency surgeries, is expanding the application base for these gels in hospitals and outpatient settings. Third, the ongoing global challenge of antibiotic resistance has shifted clinical focus toward localized antimicrobial solutions, and these gels offer a viable way to reduce systemic antibiotic use without compromising infection control. Fourth, improvements in biomaterial engineering have allowed for the production of gels that are not only highly effective but also cost-efficient and stable across different temperatures and environmental conditions, which is crucial for their use in both developed and resource-limited healthcare systems. Fifth, the expansion of military and tactical medicine programs is playing a pivotal role, with defense departments across the world integrating these gels into field kits for soldiers and medics. Sixth, patient preferences are evolving, with more people seeking treatments that promise faster recovery, lower complication risks, and less pain-factors that these gels directly address. Seventh, the growth of outpatient clinics and home healthcare services is opening new distribution channels where user-friendly, multi-purpose wound care products are in high demand. Lastly, strong backing from healthcare investors, along with R&D collaborations between biotech firms and medical institutions, is accelerating product innovation and market penetration. These drivers, in tandem, are creating a robust growth trajectory for antibacterial hemostatic gels, positioning them as an indispensable component of modern wound care across both advanced and developing healthcare systems.

SCOPE OF STUDY:

The report analyzes the Antibacterial Hemostatic Gels market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices, Other Products); End-Use (Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use, Clinics End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

  • 3M Company
  • Baxter International Inc.
  • BioTime, Inc.
  • C.R. Bard, Inc. (Becton Dickinson)
  • ConvaTec Group Plc
  • DePuy Synthes (Johnson & Johnson)
  • Fumedica AG
  • Haemonetics Corporation
  • HEMOTECH Biomed Pvt Ltd
  • Integra LifeSciences
  • Johnson & Johnson
  • Medtronic plc
  • Molnlycke Health Care
  • Novosorb Biodegradable Products
  • OMRON Corporation
  • Pfizer Inc.
  • Porcine Biotech
  • Smith & Nephew plc
  • Stryker Corporation
  • WoundCare Technologies

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Antibacterial Hemostatic Gels - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Surgical Volumes and Wound Management Needs Throw the Spotlight on Antibacterial Hemostatic Gels
    • Use in Trauma, Orthopedics, and Cardiac Surgeries Expands Market Relevance Across Specialties
    • OEMs Offering Dual-Action Hemostasis and Infection Control Enhance Surgical Efficiency
    • Growth in Emergency and Battlefield Medicine Drives Demand for Rapid-Action Gel Formulations
    • Use of Biocompatible Polymers and Silver-Based Agents Enhances Healing Outcomes
    • OEM Emphasis on Preloaded Syringes and Easy Applicators Improves OR Workflow
    • Rising Focus on Reducing Surgical Site Infections Drives Adoption of Antibacterial Technologies
    • Use in Robotic and Laparoscopic Procedures Promotes Precision Application
    • Expansion of Field Use in Remote and Resource-Limited Settings Supports Global Adoption
    • OEMs Integrating Hemostatic Gels With Advanced Wound Closure Systems Add Value to Surgical Kits
    • Use in Dental, ENT, and Neurosurgery Diversifies Clinical Use Cases
    • Growing Demand for Reabsorbable and Non-Animal-Sourced Formulations Broadens Patient Eligibility
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Antibacterial Hemostatic Gels Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Antibacterial Hemostatic Gels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Antibacterial Hemostatic Gels by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Urinanalysis Testing Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Urinanalysis Testing Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Urinanalysis Testing Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Hematology Testing Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Hematology Testing Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Hematology Testing Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Blood Pressure Monitoring Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Blood Pressure Monitoring Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Blood Pressure Monitoring Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Blood Glucose Monitoring Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Blood Glucose Monitoring Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Blood Glucose Monitoring Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Homecare End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Homecare End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 25: World 16-Year Perspective for Homecare End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Diagnostic Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Diagnostic Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 28: World 16-Year Perspective for Diagnostic Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 31: World 16-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 34: World 16-Year Perspective for Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Antibacterial Hemostatic Gels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Antibacterial Hemostatic Gels by Product - Percentage Breakdown of Value Sales for Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products for the Years 2014, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Antibacterial Hemostatic Gels by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Antibacterial Hemostatic Gels by Product - Percentage Breakdown of Value Sales for Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products for the Years 2014, 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Antibacterial Hemostatic Gels by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • JAPAN
    • Antibacterial Hemostatic Gels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 49: Japan 16-Year Perspective for Antibacterial Hemostatic Gels by Product - Percentage Breakdown of Value Sales for Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products for the Years 2014, 2025 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for Antibacterial Hemostatic Gels by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • CHINA
    • Antibacterial Hemostatic Gels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 53: China Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 55: China 16-Year Perspective for Antibacterial Hemostatic Gels by Product - Percentage Breakdown of Value Sales for Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products for the Years 2014, 2025 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 58: China 16-Year Perspective for Antibacterial Hemostatic Gels by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • EUROPE
    • Antibacterial Hemostatic Gels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Antibacterial Hemostatic Gels by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for Antibacterial Hemostatic Gels by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 64: Europe 16-Year Perspective for Antibacterial Hemostatic Gels by Product - Percentage Breakdown of Value Sales for Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products for the Years 2014, 2025 & 2030
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for Antibacterial Hemostatic Gels by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • FRANCE
    • Antibacterial Hemostatic Gels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 68: France Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: France Historic Review for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 70: France 16-Year Perspective for Antibacterial Hemostatic Gels by Product - Percentage Breakdown of Value Sales for Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products for the Years 2014, 2025 & 2030
    • TABLE 71: France Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: France Historic Review for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 73: France 16-Year Perspective for Antibacterial Hemostatic Gels by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • GERMANY
    • Antibacterial Hemostatic Gels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 74: Germany Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Germany Historic Review for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 76: Germany 16-Year Perspective for Antibacterial Hemostatic Gels by Product - Percentage Breakdown of Value Sales for Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products for the Years 2014, 2025 & 2030
    • TABLE 77: Germany Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Germany Historic Review for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 79: Germany 16-Year Perspective for Antibacterial Hemostatic Gels by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 80: Italy Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Italy Historic Review for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 82: Italy 16-Year Perspective for Antibacterial Hemostatic Gels by Product - Percentage Breakdown of Value Sales for Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products for the Years 2014, 2025 & 2030
    • TABLE 83: Italy Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Italy Historic Review for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 85: Italy 16-Year Perspective for Antibacterial Hemostatic Gels by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Antibacterial Hemostatic Gels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 86: UK Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: UK Historic Review for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 88: UK 16-Year Perspective for Antibacterial Hemostatic Gels by Product - Percentage Breakdown of Value Sales for Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products for the Years 2014, 2025 & 2030
    • TABLE 89: UK Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: UK Historic Review for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 91: UK 16-Year Perspective for Antibacterial Hemostatic Gels by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 92: Spain Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Spain Historic Review for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 94: Spain 16-Year Perspective for Antibacterial Hemostatic Gels by Product - Percentage Breakdown of Value Sales for Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products for the Years 2014, 2025 & 2030
    • TABLE 95: Spain Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Spain Historic Review for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 97: Spain 16-Year Perspective for Antibacterial Hemostatic Gels by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 98: Russia Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Russia Historic Review for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 100: Russia 16-Year Perspective for Antibacterial Hemostatic Gels by Product - Percentage Breakdown of Value Sales for Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products for the Years 2014, 2025 & 2030
    • TABLE 101: Russia Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Russia Historic Review for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 103: Russia 16-Year Perspective for Antibacterial Hemostatic Gels by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Rest of Europe Historic Review for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 106: Rest of Europe 16-Year Perspective for Antibacterial Hemostatic Gels by Product - Percentage Breakdown of Value Sales for Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products for the Years 2014, 2025 & 2030
    • TABLE 107: Rest of Europe Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Rest of Europe Historic Review for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 109: Rest of Europe 16-Year Perspective for Antibacterial Hemostatic Gels by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Antibacterial Hemostatic Gels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Antibacterial Hemostatic Gels by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 112: Asia-Pacific 16-Year Perspective for Antibacterial Hemostatic Gels by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 113: Asia-Pacific Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Asia-Pacific Historic Review for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 115: Asia-Pacific 16-Year Perspective for Antibacterial Hemostatic Gels by Product - Percentage Breakdown of Value Sales for Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products for the Years 2014, 2025 & 2030
    • TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Asia-Pacific Historic Review for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 118: Asia-Pacific 16-Year Perspective for Antibacterial Hemostatic Gels by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Antibacterial Hemostatic Gels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 119: Australia Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Australia Historic Review for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 121: Australia 16-Year Perspective for Antibacterial Hemostatic Gels by Product - Percentage Breakdown of Value Sales for Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products for the Years 2014, 2025 & 2030
    • TABLE 122: Australia Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Australia Historic Review for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 124: Australia 16-Year Perspective for Antibacterial Hemostatic Gels by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • INDIA
    • Antibacterial Hemostatic Gels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 125: India Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: India Historic Review for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 127: India 16-Year Perspective for Antibacterial Hemostatic Gels by Product - Percentage Breakdown of Value Sales for Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products for the Years 2014, 2025 & 2030
    • TABLE 128: India Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: India Historic Review for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 130: India 16-Year Perspective for Antibacterial Hemostatic Gels by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 131: South Korea Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: South Korea Historic Review for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 133: South Korea 16-Year Perspective for Antibacterial Hemostatic Gels by Product - Percentage Breakdown of Value Sales for Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products for the Years 2014, 2025 & 2030
    • TABLE 134: South Korea Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: South Korea Historic Review for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 136: South Korea 16-Year Perspective for Antibacterial Hemostatic Gels by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 137: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Asia-Pacific Historic Review for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 139: Rest of Asia-Pacific 16-Year Perspective for Antibacterial Hemostatic Gels by Product - Percentage Breakdown of Value Sales for Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products for the Years 2014, 2025 & 2030
    • TABLE 140: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Asia-Pacific Historic Review for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 142: Rest of Asia-Pacific 16-Year Perspective for Antibacterial Hemostatic Gels by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Antibacterial Hemostatic Gels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Antibacterial Hemostatic Gels by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 145: Latin America 16-Year Perspective for Antibacterial Hemostatic Gels by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 146: Latin America Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Latin America Historic Review for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 148: Latin America 16-Year Perspective for Antibacterial Hemostatic Gels by Product - Percentage Breakdown of Value Sales for Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products for the Years 2014, 2025 & 2030
    • TABLE 149: Latin America Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Latin America Historic Review for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 151: Latin America 16-Year Perspective for Antibacterial Hemostatic Gels by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 152: Argentina Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Argentina Historic Review for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 154: Argentina 16-Year Perspective for Antibacterial Hemostatic Gels by Product - Percentage Breakdown of Value Sales for Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products for the Years 2014, 2025 & 2030
    • TABLE 155: Argentina Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Argentina Historic Review for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 157: Argentina 16-Year Perspective for Antibacterial Hemostatic Gels by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 158: Brazil Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Brazil Historic Review for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 160: Brazil 16-Year Perspective for Antibacterial Hemostatic Gels by Product - Percentage Breakdown of Value Sales for Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products for the Years 2014, 2025 & 2030
    • TABLE 161: Brazil Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Brazil Historic Review for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 163: Brazil 16-Year Perspective for Antibacterial Hemostatic Gels by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 164: Mexico Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Mexico Historic Review for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 166: Mexico 16-Year Perspective for Antibacterial Hemostatic Gels by Product - Percentage Breakdown of Value Sales for Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products for the Years 2014, 2025 & 2030
    • TABLE 167: Mexico Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Mexico Historic Review for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 169: Mexico 16-Year Perspective for Antibacterial Hemostatic Gels by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 170: Rest of Latin America Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Rest of Latin America Historic Review for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 172: Rest of Latin America 16-Year Perspective for Antibacterial Hemostatic Gels by Product - Percentage Breakdown of Value Sales for Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products for the Years 2014, 2025 & 2030
    • TABLE 173: Rest of Latin America Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Rest of Latin America Historic Review for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 175: Rest of Latin America 16-Year Perspective for Antibacterial Hemostatic Gels by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Antibacterial Hemostatic Gels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Antibacterial Hemostatic Gels by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 178: Middle East 16-Year Perspective for Antibacterial Hemostatic Gels by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 179: Middle East Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Middle East Historic Review for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 181: Middle East 16-Year Perspective for Antibacterial Hemostatic Gels by Product - Percentage Breakdown of Value Sales for Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products for the Years 2014, 2025 & 2030
    • TABLE 182: Middle East Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Middle East Historic Review for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 184: Middle East 16-Year Perspective for Antibacterial Hemostatic Gels by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 185: Iran Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Iran Historic Review for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 187: Iran 16-Year Perspective for Antibacterial Hemostatic Gels by Product - Percentage Breakdown of Value Sales for Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products for the Years 2014, 2025 & 2030
    • TABLE 188: Iran Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Iran Historic Review for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 190: Iran 16-Year Perspective for Antibacterial Hemostatic Gels by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 191: Israel Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Israel Historic Review for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 193: Israel 16-Year Perspective for Antibacterial Hemostatic Gels by Product - Percentage Breakdown of Value Sales for Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products for the Years 2014, 2025 & 2030
    • TABLE 194: Israel Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Israel Historic Review for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 196: Israel 16-Year Perspective for Antibacterial Hemostatic Gels by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 197: Saudi Arabia Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Saudi Arabia Historic Review for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 199: Saudi Arabia 16-Year Perspective for Antibacterial Hemostatic Gels by Product - Percentage Breakdown of Value Sales for Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products for the Years 2014, 2025 & 2030
    • TABLE 200: Saudi Arabia Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Saudi Arabia Historic Review for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 202: Saudi Arabia 16-Year Perspective for Antibacterial Hemostatic Gels by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 203: UAE Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: UAE Historic Review for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 205: UAE 16-Year Perspective for Antibacterial Hemostatic Gels by Product - Percentage Breakdown of Value Sales for Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products for the Years 2014, 2025 & 2030
    • TABLE 206: UAE Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: UAE Historic Review for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 208: UAE 16-Year Perspective for Antibacterial Hemostatic Gels by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 209: Rest of Middle East Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Rest of Middle East Historic Review for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 211: Rest of Middle East 16-Year Perspective for Antibacterial Hemostatic Gels by Product - Percentage Breakdown of Value Sales for Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products for the Years 2014, 2025 & 2030
    • TABLE 212: Rest of Middle East Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Rest of Middle East Historic Review for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 214: Rest of Middle East 16-Year Perspective for Antibacterial Hemostatic Gels by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • AFRICA
    • Antibacterial Hemostatic Gels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 215: Africa Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Africa Historic Review for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 217: Africa 16-Year Perspective for Antibacterial Hemostatic Gels by Product - Percentage Breakdown of Value Sales for Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products for the Years 2014, 2025 & 2030
    • TABLE 218: Africa Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Africa Historic Review for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 220: Africa 16-Year Perspective for Antibacterial Hemostatic Gels by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use for the Years 2014, 2025 & 2030

IV. COMPETITION